More Articles

Access and Evidence

Payers and the ABCs of digital literacy

Katie Osborne, (Sep 24, 2021)

Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them
Medical

Nurturing peer-to-peer interactions in a virtual world  

Lucy Fulford, (Sep 21, 2021)

The serendipitous nature of face-to-face peer interactions is hard to recreate in digital contexts but a focus on small, two-way interactions can yield fruitful peer-to-peer engagement online 
Patients and Medical

Medical Affairs & Social Media: A Brave New World

Andrew Stone, (Sep 17, 2021)

A great majority of healthcare providers now use social media platforms. Medical Affairs teams need to amplify their voice on social media channels – or lose out. 
Multichannel

How well is pharma incubating innovation?

Andrew Stone, (Jul 7, 2021)

Incubators are starting to prove their worth by enabling pharma to explore new tech and by challenging pharma’s internal culture
Access and Evidence

Decoding the patient journey with RWD

Lucy Fulford, (Jul 6, 2021)

Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise
Multichannel

Innovating with the wizards of AI

Andrew Stone, (Jul 5, 2021)

New applications for AI are opening up vast possibilities in healthcare if pharma can collaborate to innovate
Commercial

Unlocking the full potential of biosimilars

Pamela Whitby, (Jul 2, 2021)

The future looks bright for biosimilars in an age of crisis over healthcare affordability
Medical

Transforming cancer care through earlier intervention 

Anonymous (not verified), (Jun 24, 2021)

In our Q&A with Dave Fredrickson, we explore the efforts to continue innovating and bringing better care to cancer patients during and beyond the pandemic
Access and Evidence

Keeping it real: How data is driving healthcare reform in China 

Pamela Whitby, (Jun 8, 2021)

China’s healthcare market is ripe for those capable of helping it capture the vast potential of real-world data
Medical

On the journey from pill to platform

Andrew Stone, (Jun 3, 2021)

For AstraZeneca’s Alex Bedenkov, investing more in post-pandemic medical capabilities is just the start of a far more profound organisation-wide transformation

Pages